(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-piperazin-1-yl-methanone, 95.0%, 1g

3-Pyrrolidin-1-ylmethyl-piperidine, 95.0%, 500mg

(1R,4S)-4-((tert-Butoxycarbonyl)amino)cyclopent-2-enecarboxylic acid, 95.0%, 5g

Ethyl 2-(2-hydroxyphenyl)acetate, 95.0%, 25g

(3-phenyl-2-propyn-1-yl)propylamine, 95.0%, 5g

Adamantan-2-amine, 95.0%, 100g

2-methyl-1-(pyridin-4-yl)propan-1-ol, 95.0%, 1g

1-Boc-Octahydropyrrolo[3,4-b]pyridine, 95.0%, 10g

Ethyl 3-methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-2-carboxylate, 97%, 5g

4-(2-Acetoxyethoxy)toluene>98.0%(GC)10g

1,4-Dithioerythritol (DTE), 10 g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-chlorobenzoic acid, 95.0%, 5g

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 2.00 µm, 1 Piece(s)